SCHEMBL11360275

SCHEMBL11360275

C/N=C(\NC#N)NCCNCc1csc(Cc2ccccc2)n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 2/20 0.43
▸ CYP2D6 P10635 2/20 0.43
▸ MAPT P10636 2/20 0.43
▸ HRH2 P25021 1/20 0.43
▸ HDAC1 Q13547 3/20 0.41
▸ HDAC6 Q9UBN7 3/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ HDAC8 Q9BY41 1/20 0.37
▸ KLKB1 P03952 3/20 0.36
▸ KLK1 P06870 1/20 0.36
▸ HRH4 Q9H3N8 3/20 0.35
▸ CDK5 Q00535 1/20 0.35
▸ CDK5R1 Q15078 1/20 0.35
▸ HRH3 Q9Y5N1 1/20 0.34
▸ ENPP2 Q13822 1/20 0.34
▸ QPCT Q16769 1/20 0.34
▸ ADRB3 P13945 1/20 0.34
▸ LMNA P02545 2/20 0.33
▸ HPGD P15428 1/20 0.33
▸ TSHR P16473 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11360291 1.00 CYP3A4 (0.43) CYP3A4CYP2D6MAPTHRH2HDAC1
SCHEMBL11355242 0.87 CYP3A4 (0.48) CYP3A4CYP2D6MAPTHRH2SMN1; SMN2
SCHEMBL11360285 0.84 HDAC1 (0.42) MAPTHDAC1HDAC6SMN1; SMN2HDAC8
SCHEMBL11365176 0.84 CYP3A4 (0.62) CYP3A4CYP2D6MAPTHRH2HDAC1
SCHEMBL11365172 0.84 CYP3A4 (0.62) CYP3A4CYP2D6MAPTHRH2HDAC1
SCHEMBL11360887 0.80 CYP3A4 (0.48) CYP3A4CYP2D6MAPTHRH2SMN1; SMN2
SCHEMBL11364166 0.79 CYP3A4 (0.50) CYP3A4CYP2D6MAPTHRH2SMN1; SMN2
SCHEMBL11364909 0.79 CYP3A4 (0.47) CYP3A4CYP2D6MAPTHRH2SMN1; SMN2
SCHEMBL11364897 0.79 CYP3A4 (0.47) CYP3A4CYP2D6MAPTHRH2SMN1; SMN2
SCHEMBL11364178 0.79 CYP3A4 (0.50) CYP3A4CYP2D6MAPTHRH2SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4293699-A CONTAINING A BENZIMIDAZOLE OR 3-/5,6,7,8-TETRAHYDROIMIDAZO(1,5A)PYRIDINE, ANTIHISTAMINES SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1981-10-06 — — US disclosed
US-4287198-A ANTIHISTAMINES SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1981-09-01 — — US disclosed
US-4228291-A INHIBITORS OF HISTAMINE ACTIVITY SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1980-10-14 — — US disclosed
US-4221802-A Pharmacologically active guanidine compounds for inhibiting H-2 histamine receptors SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1980-09-09 — — US disclosed
US-4154844-A ANTIHISTAMINE, GASTRIC JUICE ANTISECRETORY AGENTS SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1979-05-15 — — US disclosed
US-4137237-A ANTIHISTAMINES SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1979-01-30 — — US disclosed
US-4070475-A THIOALKYL-, AMINOALKYL-, AND OXYALKYL- SUBSTITUTED GUANIDINES SMITH KLINE & FRENCH LABORATORIES LIMITED (EN) 1978-01-24 — — US disclosed
US-4024271-A INHIBITORS OF HISTAMINE ACTIVITY SMITH KLINE & FRENCH LABORATORIES LIMITED (EN) 1977-05-17 — — US disclosed
US-3950333-A HISTAMINE INHIBITORS, OXYALKYL, THIOALKYL, AMINOALKYL DERIVATIVES SMITH KLINE & FRENCH LABORATORIES LIMITED (EN) 1976-04-13 — — US disclosed
Send feedback